Correlation Between Abeona Therapeutics and Immunocore Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abeona Therapeutics and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abeona Therapeutics and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abeona Therapeutics and Immunocore Holdings, you can compare the effects of market volatilities on Abeona Therapeutics and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abeona Therapeutics with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abeona Therapeutics and Immunocore Holdings.

Diversification Opportunities for Abeona Therapeutics and Immunocore Holdings

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Abeona and Immunocore is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Abeona Therapeutics and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Abeona Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abeona Therapeutics are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Abeona Therapeutics i.e., Abeona Therapeutics and Immunocore Holdings go up and down completely randomly.

Pair Corralation between Abeona Therapeutics and Immunocore Holdings

Given the investment horizon of 90 days Abeona Therapeutics is expected to generate 1.06 times more return on investment than Immunocore Holdings. However, Abeona Therapeutics is 1.06 times more volatile than Immunocore Holdings. It trades about 0.11 of its potential returns per unit of risk. Immunocore Holdings is currently generating about -0.05 per unit of risk. If you would invest  546.00  in Abeona Therapeutics on August 31, 2024 and sell it today you would earn a total of  95.00  from holding Abeona Therapeutics or generate 17.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Abeona Therapeutics  vs.  Immunocore Holdings

 Performance 
       Timeline  
Abeona Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Abeona Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Abeona Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Immunocore Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunocore Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Abeona Therapeutics and Immunocore Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abeona Therapeutics and Immunocore Holdings

The main advantage of trading using opposite Abeona Therapeutics and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abeona Therapeutics position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.
The idea behind Abeona Therapeutics and Immunocore Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum